Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Odonate Therapeutics Inc (ODT)

Odonate Therapeutics Inc (ODT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 43,109
  • Shares Outstanding, K 38,490
  • Annual Sales, $ 0 K
  • Annual Income, $ -126,350 K
  • 60-Month Beta 0.46
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade ODT with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -1.85
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 06/03/22
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Options Overview Details

View History
  • Implied Volatility 0.00% ( unch)
  • Historical Volatility N/A
  • IV Percentile 0%
  • IV Rank N/A
  • IV High 0.00% on N/A
  • IV Low 0.00% on N/A
  • Put/Call Vol Ratio N/A
  • Today's Volume N/A
  • Volume Avg (30-Day) N/A
  • Put/Call OI Ratio N/A
  • Today's Open Interest N/A
  • Open Int (30-Day) N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.85 +31.76%
on 01/07/22
1.65 -32.12%
on 12/22/21
-0.36 (-24.32%)
since 12/14/21
3-Month
0.85 +31.76%
on 01/07/22
3.49 -67.91%
on 11/15/21
-1.95 (-63.52%)
since 10/14/21
52-Week
0.85 +31.76%
on 01/07/22
7.10 -84.23%
on 02/08/21
-3.94 (-77.87%)
since 01/14/21

Most Recent Stories

More News
Odonate Announces Expected Delisting of Its Stock

Odonate Therapeutics, Inc. (NASDAQ: ODT) today announced that on January 6, 2022 it received written notice from The Nasdaq Stock Market LLC (“Nasdaq”) notifying Odonate that Nasdaq believes that...

ODT : 1.12 (-4.27%)
Odonate Therapeutics Announces Planned Return of Capital to Stockholders through Share Repurchase Plan

Odonate Therapeutics, Inc. (NASDAQ: ODT) today announced that it will commence a share repurchase plan for up to 20 million shares in order to return capital to stockholders. This action is in connection...

ODT : 1.12 (-4.27%)
Odonate Therapeutics Announces Financial Results for the Three and Nine Months Ended September 30, 2021

Odonate Therapeutics, Inc. (NASDAQ: ODT) today announced financial results for the three and nine months ended September 30, 2021.

ODT : 1.12 (-4.27%)
SHAREHOLDER ALERT: Morris Kandinov Investigating ODT, AYTU, EAR, and CORT; Shareholders are Encouraged to Contact the Firm

SAN DIEGO, Sept. 08, 2021 (GLOBE NEWSWIRE) -- National law firm Morris Kandinov is investigating the actions of the officers and board of directors of Odonate Therapeutics, Inc., Aytu Biopharma, Inc.,...

ODT : 1.12 (-4.27%)
AYTU : 0.5718 (+3.59%)
EAR : 1.2900 (+0.78%)
CORT : 21.00 (+4.43%)
ODONATE INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Odonate Therapeutics, Inc. - ODT

Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into Odonate Therapeutics,...

ODT : 1.12 (-4.27%)
NASDAQ: ODT Investor Notice: Update in Lawsuit against Odonate Therapeutics, Inc. announced by Shareholders Foundation

SAN DIEGO, Aug. 10, 2021 (GLOBE NEWSWIRE) -- The Shareholders Foundation, Inc. announces an update in the lawsuit that is pending for certain investors in Odonate Therapeutics, Inc. (NASDAQ: ODT) shares. ...

ODT : 1.12 (-4.27%)
The Law Offices of Frank R. Cruz Announces Investigation of Odonate Therapeutics, Inc. (ODT) on Behalf of Investors

The Law Offices of Frank R. Cruz is investigating potential claims against the board of directors of Odonate Therapeutics, Inc. (“Odonate” or the “Company”) (NASDAQ: ODT ) concerning whether...

ODT : 1.12 (-4.27%)
Odonate Therapeutics Announces Financial Results for the Three and Six Months Ended June 30, 2021

Odonate Therapeutics, Inc. (NASDAQ: ODT) today announced financial results for the three and six months ended June 30, 2021.

ODT : 1.12 (-4.27%)
Odonate Therapeutics Announces Financial Results for the Three Months Ended March 31, 2021

Odonate Therapeutics, Inc. (NASDAQ: ODT) today announced financial results for the three months ended March 31, 2021.

ODT : 1.12 (-4.27%)
Odonate Therapeutics Announces Discontinuation of Development of Tesetaxel

Following feedback from the U.S. Food and Drug Administration (FDA) in a pre-New Drug Application meeting, Odonate Therapeutics, Inc. (NASDAQ: ODT) has concluded that the clinical data package for tesetaxel...

ODT : 1.12 (-4.27%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Odonate Therapeutics, LLC is a pharmaceutical company. It engaged in the development of therapeutics to improve and extend the lives of patients with cancer. The company focused on the development of tesetaxel, a novel chemotherapy agent. It has completed Phase-II studies in patients with metastatic...

See More

Key Turning Points

3rd Resistance Point 1.27
2nd Resistance Point 1.23
1st Resistance Point 1.18
Last Price 1.12
1st Support Level 1.09
2nd Support Level 1.05
3rd Support Level 1.00

See More

52-Week High 7.10
Fibonacci 61.8% 4.71
Fibonacci 50% 3.98
Fibonacci 38.2% 3.24
Last Price 1.12
52-Week Low 0.85

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar